HSG Staff

Huntington Study Group Staff

Shari Kinel, JD
Executive Director

   (585) 242-0276

Shari has been the Executive Director to the Huntington Study Group since 2009. She is a graduate of Brandeis University and she earned a law degree from SUNY Buffalo. Shari manages the overall operations of HSG and oversees governance, grants, contracts, and key objectives and strategies of HSG. Since joining HSG, Shari has served on HD clinical trial steering committees, HD trial project teams and has dedicated a lot of her time working with HD care and community groups. Shari is an attorney who started her career at the US Department of Labor and the US Department of Justice in Washington, DC. She then joined Chase Manhattan’s Bank’s legal team and also spent time on the legal staff at Celltech Pharmaceuticals. Shari also had her own practice representing organizations in business matters involving regulatory compliance, contracts, and corporate policies and procedures.

Anne Van Dusen, CHC
Director of Operations

   (585) 244-9487

Anne Van Dusen joined the HSG team in June of 2017 as the Director of Education & Special Programs and was promoted to the position of Director of Operations in 2018. She has developed and implemented educational plans that will sustain and help HSG to maintain its standing as a proven world leader in facilitating high quality clinical research trials and studies in Huntington disease. Van Dusen holds a BS from the University of Binghamton School of Management and is certified in healthcare compliance by the Compliance Certification Board. Prior to joining HSG, she held leadership roles in compliance and finance, most recently at CCSI of Rochester, ACM Medical Laboratory, and Lifetime Care Home Care and Hospice.

Kristin Strazdins
Manager, Finance & Special Projects

   (585) 242-0967

Kristin Strazdins is the Manager, Finance & Special Projects and has worked for HSG since February 2014. She handles all accounting functions and manages the HSG office and human resource needs. She handled accounting functions and site payments for First/ARC, which produced the second FDA-approved drug for Huntington disease. For SIGNAL, she handles the site payments and accounting, and arranges travel, travel reimbursement, and participant payment for participants in the trial. Prior to working for HSG, Strazdins worked as a Staff Accountant in a public accounting firm for seven years.

Kevin Gregory
Director of Education, Communication & Outreach

   (585) 244-8804

Kevin Gregory joined the Huntington Study Group in September 2018. He operates the HSG website and social media platforms of the HSG, and ensures a strong presence within the HD community through those channels. He is also responsible for maintaining the Huntington Study Group’s core learning platform, CME4HD. Before joining HSG, he was a Director on the Medicare appeals program at MAXIMUS for thirteen years. Prior to that, he spent five years managing e-learning development at Element K, plus three years in corporate video and news production. Kevin is a certified Project Manager Professional (PMP), with degrees in communications from MCC and SUNY Fredonia.

Janine Mercandetti
Manager, Projects and Contracts

   (585) 242-0277

Janine Mercandetti joined the Huntington Study Group in March 2019. She is responsible for coordinating contract/amendment delivery, document control, system standardization and maintenance, and project management within HSG. Prior to joining HSG, Janine was a Sr. Proposal Manager with Spectrum Enterprise for 7 years where she managed and supported all operational activities throughout the lifecycle of multiple proposals. Janine holds a BFA from DePaul University.

Lauren Falanga
Manager of Clinical Collaborations

 

Lauren Falanga joined the HSG team in April 2019 as the Manager of Clinical Collaborations. Lauren’s role at the HSG includes creation of collaborative and sustained relationships with Industry, Academics and other Research Entities that will result in accelerated achievements in seeking treatments that will make a difference for those impacted by HD. She has over 15 years of experience in medical laboratory operations including medical technologist and supervisory roles. She worked in the Clinical Trials sector of laboratory operations for more than 5 years where she led all global harmonization initiatives and projects. She also provided scientific information and guidance for Clinical Trials global operations.